Citadel Advisors’s Elanco Animal Health ELAN Stock Holding History

Citadel Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Sell	53,700 -26,300	-33%	-$608K	﹤0.01%	7518
2026 Q1	$1.91M	Buy	80,000 +700	+0.9%	+$17.1K	﹤0.01%	6146
2025 Q4	$1.79M	Buy	79,300 +3,700	+5%	+$80.5K	﹤0.01%	6147
2025 Q3	$1.52M	Buy	75,600 +12,100	+19%	+$203K	﹤0.01%	6642
2025 Q2	$907K	Sell	63,500 -29,500	-32%	-$345K	﹤0.01%	7328
2025 Q1	$977K	Sell	93,000 -11,500	-11%	-$130K	﹤0.01%	7012
2024 Q4	$1.27M	Buy	104,500 +23,700	+29%	+$310K	﹤0.01%	6547
2024 Q3	$1.19M	Buy	80,800 +5,400	+7%	+$75.2K	﹤0.01%	6520
2024 Q2	$1.09M	Buy	75,400 +9,500	+14%	+$152K	﹤0.01%	6418
2024 Q1	$1.07M	Sell	65,900 -47,700	-42%	-$746K	﹤0.01%	6773
2023 Q4	$1.69M	Buy	113,600 +28,500	+33%	+$323K	﹤0.01%	5669
2023 Q3	$957K	Sell	85,100 -158,600	-65%	-$1.84M	﹤0.01%	6642
2023 Q2	$2.45M	Buy	243,700 +27,400	+13%	+$254K	﹤0.01%	4804
2023 Q1	$2.03M	Sell	216,300 -18,300	-8%	-$216K	﹤0.01%	5333
2022 Q4	$2.87M	Sell	234,600 -59,900	-20%	-$747K	﹤0.01%	4827
2022 Q3	$3.65M	Buy	294,500 +204,400	+227%	+$3.57M	﹤0.01%	4419
2022 Q2	$1.77M	Sell	90,100 -479,200	-84%	-$11.3M	﹤0.01%	5800
2022 Q1	$14.9M	Buy	569,300 +249,500	+78%	+$6.64M	﹤0.01%	2383
2021 Q4	$9.08M	Buy	319,800 +205,300	+179%	+$6.39M	﹤0.01%	3236
2021 Q3	$3.65M	Sell	114,500 -540,400	-83%	-$18.1M	﹤0.01%	4935
2021 Q2	$22.7M	Buy	654,900 +426,700	+187%	+$14.1M	0.01%	1928
2021 Q1	$6.72M	Sell	228,200 -850,700	-79%	-$26.2M	﹤0.01%	3666
2020 Q4	$33.1M	Buy	1,078,900 +1,004,200	+1,344%	+$30.6M	0.01%	1301
2020 Q3	$2.09M	Buy	74,700 +1,800	+2%	+$45.6K	﹤0.01%	4634
2020 Q2	$1.56M	Sell	72,900 -14,500	-17%	-$320K	﹤0.01%	4997
2020 Q1	$1.96M	Buy	87,400 +45,000	+106%	+$1.23M	﹤0.01%	4176
2019 Q4	$1.25M	Buy	42,400 +14,600	+53%	+$397K	﹤0.01%	5203
2019 Q3	$739K	Sell	27,800 -1,700	-6%	-$51K	﹤0.01%	6101
2019 Q2	$997K	Sell	29,500 -131,800	-82%	-$4.28M	﹤0.01%	5700
2019 Q1	$5.17M	Buy	+161,300	New	+$4.96M	﹤0.01%	2957

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Citadel Advisors's ELAN Position: Q2 2026 in Review

Citadel Advisors increased its Elanco Animal Health (ELAN) stake by 120% in Q2 2026, buying an estimated $122M and bringing the position to 9,668,611 shares worth $238M. The position accounts for 0.03% of the portfolio, ranked #471.

Citadel Advisors first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $251M in Q1 2019. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Citadel Advisors held 9,668,611 shares of Elanco Animal Health worth $238M as of Q2 2026.
Citadel Advisors bought 5,281,484 Elanco Animal Health shares in Q2 2026, an estimated $122M.
Elanco Animal Health made up 0.03% of Citadel Advisors's portfolio in Q2 2026, its #471 holding.
Citadel Advisors first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
Citadel Advisors's Elanco Animal Health position peaked at $251M in Q1 2019.
522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.